Mangoceuticals (MGRX) Depreciation & Amortization (CF) (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $250.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $250.0; the trailing twelve-month figure through Mar 2026 stood at $1013.0 (down 74.43% YoY), and the FY2025 full-year result was $1012.0, down 89.81% from the prior year.
• Depreciation & Amortization (CF) declined to $250.0 in Q1 2026, from $255.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $12515.0 in Q3 2023 to a low of $250.0 in Q1 2025.
• A 4-year average of $3526.0 and a median of $1856.5 in 2024 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) increased 2.33% in 2024 and plunged 95.98% in 2025, its largest moves.
• Tracing MGRX's Depreciation & Amortization (CF) over 4 years: stood at $6292.0 in 2023, then slumped by 95.95% to $255.0 in 2024, then changed by 0.0% to $255.0 in 2025, then retreated by 1.96% to $250.0 in 2026.
• Business Quant data shows MGRX's Depreciation & Amortization (CF) at $250.0 in Q1 2026, $255.0 in Q4 2025, and $256.0 in Q3 2025.